| 000 | 01797 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514233823.0 | ||
| 264 | 0 | _c20050819 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0022-4790 | ||
| 024 | 7 |
_a10.1002/jso.20297 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakkenberg, R B | |
| 245 | 0 | 0 |
_aPalliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients. _h[electronic resource] |
| 260 |
_bJournal of surgical oncology _cAug 2005 |
||
| 300 |
_a107-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xsecondary |
| 650 | 0 | 4 | _aCatheter Ablation |
| 650 | 0 | 4 | _aChemotherapy, Cancer, Regional Perfusion |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aExtremities |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMelphalan _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPalliative Care _xmethods |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xsecondary |
| 650 | 0 | 4 | _aTourniquets |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadministration & dosage |
| 700 | 1 | _aVrouenraets, B C | |
| 700 | 1 | _avan Geel, A N | |
| 700 | 1 | _aNieweg, O E | |
| 700 | 1 | _aNoorda, E M | |
| 700 | 1 | _aEggermont, A M M | |
| 700 | 1 | _aKroon, B B R | |
| 773 | 0 |
_tJournal of surgical oncology _gvol. 91 _gno. 2 _gp. 107-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jso.20297 _zAvailable from publisher's website |
| 999 |
_c15683183 _d15683183 |
||